3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine
C23H24F2N6 — CID 134327731
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine
3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine (PubChem CID 134327731) has the molecular formula C23H24F2N6 and a molecular weight of 422.48 g/mol. Its IUPAC name is 3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine.
Molecular Properties
| Compound Name | 3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine |
|---|---|
| PubChem CID | 134327731 |
| Molecular Formula | C23H24F2N6 |
| Molecular Weight | 422.48 g/mol |
| Exact Mass | 422.20 |
| IUPAC Name | 3-[3,5-difluoro-4-[3-(1-methylpyrazol-4-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl]phenyl]-N-propan-2-ylcyclobutan-1-amine |
| SMILES | CC(C)NC1CC(c2cc(F)c(-c3cc4c(-c5cnn(C)c5)n[nH]c4cn3)c(F)c2)C1 |
| InChI | InChI=1S/C23H24F2N6/c1-12(2)28-16-4-13(5-16)14-6-18(24)22(19(25)7-14)20-8-17-21(10-26-20)29-30-23(17)15-9-27-31(3)11-15/h6-13,16,28H,4-5H2,1-3H3,(H,29,30) |
| InChIKey | FFJSLPDQABFYSZ-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 71.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.48 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134327731 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.